No Data
No Data
Nanjing Vishee Medical Technology Co., Ltd. (688580.SH) will actively lay out the silver hair economy and continue to launch more high-quality health products.
On August 9th, Gelunhui reported that Nanjing Vishee Medical Technology Co., Ltd. (688580.SH) stated on the investor interaction platform that the company has long attached great importance to the business layout of the silver economy sector. Through years of accumulation, it has formed a rich matrix of rehabilitation products related to the silver economy, covering multiple subdivisions in fields such as neurological rehabilitation, sports rehabilitation, pelvic floor rehabilitation, mental and psychological rehabilitation, critical illness rehabilitation, pain rehabilitation, and elderly chronic diseases rehabilitation, providing customers with high-quality products and solutions: ① The company's transcranial magnetic products can be used for the detection and evaluation of neurological function in rehabilitation, psychiatry, and neurology, as well as the treatment of related diseases such as Parkinson's, insomnia, and stroke.
Nanjing Vishee Medical Technology Co., Ltd. (688580.SH) has repurchased 0.3904% of its shares.
Nanjing Vishee Medical Technology Co., Ltd (688580.SH) announced on August 1 that as of July 31, 2024, the company has repurchased a total of 373,866 shares of the company through the Shanghai Stock Exchange by means of centralized bidding trading, accounting for 0.3904% of the company's total share capital of 95,771,288 shares. The highest purchase price is 65.88 yuan/share, the lowest price is 24.91 yuan/share, and the total amount paid is RMB 18,607,663.21 (excluding stamp duty, transaction commission and other transaction fees).
Nanjing Vishee Medical Technology Co., Ltd. (688580.SH): Overseas business is still in incubation and will not have a significant impact on the company's performance for the time being.
Vishee Medical Technology Co., Ltd. (688580.SH) recently stated during a visit with institutional investors that overseas markets are a much broader market. The company has a long-term positive attitude towards expanding its business into overseas markets. In 2023, the company obtained FDA certification for its molding magnetic and pelvic floor functional magnetic products and has gradually begun participating in some foreign exhibitions. Currently, the company is speeding up its registration and compliance for overseas markets, while also building an international sales network to promote international development. However, in the short term, overseas business is still in its infancy and will not have a significant impact on the company's performance.
Nanjing Vishee Medical Technology Co., Ltd (688580.SH): The photonic medical beauty products have gained considerable sales revenue.
Vishee Medical Technology Co., Ltd. (688580.SH) recently stated during a reception with institutional investors that the company's photonic energy source equipment for sale in 2024 mainly includes Private Electric, Private Magnetic, Private Radio Frequency, and Body-Shaping Magnetic. The Private series products can meet various needs for female intimate anti-aging. Body-Shaping Magnetic products can meet needs for body shaping and slimming, and all of the above products can be used in maternal and child health institutions, medical beauty institutions, etc. As of the first half of this year, the company's photonic medical beauty products have achieved considerable sales revenue. At the same time, the in-research Picosecond Laser has the ability to treat skin pigment-related diseases and remove wrinkles.
Nanjing Vishee Medical Technology Co., Ltd (688580.SH): will promote a comprehensive upgrade of electric stimulation product technology this year.
On July 25th, Gelonhui reported that Nanjing Vishee Medical Technology Co., Ltd. (688580.SH) stated during a recent institutional investor reception that by 2024, the company will target the forefront of industrial technology, continuously promote the upgrading of product technology and performance, expand application areas, and adapt to the scope of indications. Among them, in the field of magnetic stimulation, the company actively layout clinical applications for precise targeted treatment of depression and anxiety. The MagNeuro ONE series of products with automatic navigation smoothly completed the certification and listing process in 2024. Based on traditional transcranial magnetic stimulation equipment, the system introduces magnetic resonance imaging of the brain. Related medical image processing and analysis system, which can achieve transcranial magnetic stimulation.
Nanjing Vishee Medical Technology Co., Ltd. (688580.SH): will further consolidate and enhance the market share of core business in the second half of the year, and increase efforts to develop emerging business markets.
Nanjing Vishee Medical Technology Co., Ltd (688580.SH) recently stated during a reception for institutional investors that various production and operation work were steadily progressing in the second quarter. As for specific information regarding the first half year business performance, please pay attention to the semi-annual report disclosed by the company on August 29. In the second half of the year, the company will further consolidate and enhance the market share of core business (pelvic floor and postpartum rehabilitation, psychological rehabilitation, neurological rehabilitation), increase efforts to explore emerging business markets (photoelectric medical beauty, urology), steadily improve the company's income level, and create new performance growth points.
No Data